Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Enhanced Antitumor Efficacy through an "AND gate" Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Approach

E. Jäger, J. Humajová, Y. Dölen, J. Kučka, A. Jäger, R. Konefał, J. Pankrác, E. Pavlova, T. Heizer, L. Šefc, M. Hrubý, CG. Figdor, M. Verdoes

. 2021 ; 10 (13) : e2100304. [pub] 20210529

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025413

Anticancer drug delivery strategies are designed to take advantage of the differential chemical environment in solid tumors independently, or to high levels of reactive oxygen species (ROS) or to low pH, compared to healthy tissue. Here, the design and thorough characterization of two functionalizable "AND gate" multiresponsive (MR) block amphiphilic copolymers are reported, aimed to take full advantage of the coexistence of two chemical cues-ROS and low pH-present in the tumor microenvironment. The hydrophobic blocks contain masked pH-responsive side chains, which are exposed exclusively in response to ROS. Hence, the hydrophobic polymer side chains will undergo a charge shift in a very relevant pH window present in the extracellular milieu in most solid tumors (pH 5.6-7.2) after demasking by ROS. Doxorubicin (DOX)-loaded nanosized "AND gate" MR polymersomes (MRPs) are fabricated via microfluidic self-assembly. Chemical characterization reveals ROS-dependent pH sensitivity and accelerated DOX release under influence of both ROS and low pH. Treatment of tumor-bearing mice with DOX-loaded nonresponsive and "AND gate" MRPs dramatically decreases cardiac toxicity. The most optimal "AND gate" MRPs outperform free DOX in terms of tumor growth inhibition and survival, shedding light on chemical requirements for successful cancer nanomedicine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025413
003      
CZ-PrNML
005      
20211026133836.0
007      
ta
008      
211013s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/adhm.202100304 $2 doi
035    __
$a (PubMed)34050625
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Jäger, Eliézer $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic $u Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, Nijmegen, 6525 GA, The Netherlands
245    10
$a Enhanced Antitumor Efficacy through an "AND gate" Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Approach / $c E. Jäger, J. Humajová, Y. Dölen, J. Kučka, A. Jäger, R. Konefał, J. Pankrác, E. Pavlova, T. Heizer, L. Šefc, M. Hrubý, CG. Figdor, M. Verdoes
520    9_
$a Anticancer drug delivery strategies are designed to take advantage of the differential chemical environment in solid tumors independently, or to high levels of reactive oxygen species (ROS) or to low pH, compared to healthy tissue. Here, the design and thorough characterization of two functionalizable "AND gate" multiresponsive (MR) block amphiphilic copolymers are reported, aimed to take full advantage of the coexistence of two chemical cues-ROS and low pH-present in the tumor microenvironment. The hydrophobic blocks contain masked pH-responsive side chains, which are exposed exclusively in response to ROS. Hence, the hydrophobic polymer side chains will undergo a charge shift in a very relevant pH window present in the extracellular milieu in most solid tumors (pH 5.6-7.2) after demasking by ROS. Doxorubicin (DOX)-loaded nanosized "AND gate" MR polymersomes (MRPs) are fabricated via microfluidic self-assembly. Chemical characterization reveals ROS-dependent pH sensitivity and accelerated DOX release under influence of both ROS and low pH. Treatment of tumor-bearing mice with DOX-loaded nonresponsive and "AND gate" MRPs dramatically decreases cardiac toxicity. The most optimal "AND gate" MRPs outperform free DOX in terms of tumor growth inhibition and survival, shedding light on chemical requirements for successful cancer nanomedicine.
650    _2
$a zvířata $7 D000818
650    _2
$a doxorubicin $x farmakologie $7 D004317
650    _2
$a nosiče léků $7 D004337
650    _2
$a lékové transportní systémy $7 D016503
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a myši $7 D051379
650    _2
$a micely $7 D008823
650    12
$a nanomedicína $7 D050997
650    12
$a nanočástice $7 D053758
650    _2
$a kyslík $7 D010100
650    _2
$a reaktivní formy kyslíku $7 D017382
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Humajová, Jana $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovska 1, Prague, 120 00, Czech Republic
700    1_
$a Dölen, Yusuf $u Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, Nijmegen, 6525 GA, The Netherlands
700    1_
$a Kučka, Jan $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic
700    1_
$a Jäger, Alessandro $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic
700    1_
$a Konefał, Rafał $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic
700    1_
$a Pankrác, Jan $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, Prague, 120 00, Czech Republic
700    1_
$a Pavlova, Ewa $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic
700    1_
$a Heizer, Tomáš $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, Prague, 120 00, Czech Republic
700    1_
$a Šefc, Luděk $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, Prague, 120 00, Czech Republic
700    1_
$a Hrubý, Martin $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, Prague, 162 06, Czech Republic
700    1_
$a Figdor, Carl G $u Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, Nijmegen, 6525 GA, The Netherlands $u Oncode Institute, Geert Grooteplein Zuid 26, Nijmegen, 6525 GA, The Netherlands $u Institute for Chemical Immunology, Geert Grooteplein Zuid 26, Nijmegen, 6525 GA, The Netherlands
700    1_
$a Verdoes, Martijn $u Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, Nijmegen, 6525 GA, The Netherlands $u Institute for Chemical Immunology, Geert Grooteplein Zuid 26, Nijmegen, 6525 GA, The Netherlands
773    0_
$w MED00189489 $t Advanced healthcare materials $x 2192-2659 $g Roč. 10, č. 13 (2021), s. e2100304
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34050625 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133842 $b ABA008
999    __
$a ok $b bmc $g 1714450 $s 1145920
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 13 $d e2100304 $e 20210529 $i 2192-2659 $m Advanced healthcare materials $n Adv Healthc Mater $x MED00189489
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace